Add Formweb to your mobile device
12/1/20 mb COVID-19 Monoclonal Antibody Process
December 4, 2020
From: "Madeline Belk" <madeline.belk@hhsys.org>
Sent: Tuesday, December 1, 2020 8:06:50 AM
Subject: COVID-19 Monoclonal Antibody Process
Pharmacists,
As you may have heard, we have new monoclonal antibodies for the treatment of COVID-19. These mabs are bamlanivimab (Eli Lilly) and casirivimab/imdevimab (Regeneron). They are approved under an Emergency Use Authorization (EUA) for administration in the outpatient setting. At this time, the medications are being infused at the Fever and Flu Clinic. This is a referral only process. If a physician would like their patient to receive the medication they must contact the Fever and Flu Clinic. This can be done two ways:
- Monday-Friday, 9am-5pm: Call the clinic at (256)755-2041 and ask to speak to Emily Lambert or Cindy Rogers
- After hours: Go to https://www.signupgenius.com/go/70A0D4AADA829A7F94-fever and place referring provider's name and email in information boxes (cannot contain PHI). You must then send an email through Huntsville Hospital system (.hhsys.org) to both Emily.lambert@hhsys.org and Daniel.neuberger@hhsys.org containing MRN.
The above information has been distributed to the physician staff. NO physician (including ID) can order this medication directly- they must refer to the Fever & Flu Clinic. We are currently not infusing this medication inpatient.
We will continue to update you all as this process is subject to change as we receive more directives. Please feel free to reach out if you have any questions.